Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A malignant neoplasm characterized by the presence of atypical mesenchymal-stromal cells. Representative examples include endometrial stromal sarcoma and prostate stromal sarcoma.
Biomarker and diagnostic research for stromal sarcoma has been reported in the published literature.
4 clinical trials registered, 3 recruiting. Interventions under study include drug therapy, other interventions, and biologic therapy. Pipeline includes 3 PHASE2. Research is sponsored by a mix of industry and academic institutions.
317 publications have been identified in PubMed for stromal sarcoma. Kisho has analyzed 52 by research type. Research spans Case Report / Case Series (38%), Review / Meta-Analysis (23%), and Diagnostic / Biomarker (19%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 20 |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 5:06 AM UTC
38%
Research summaries | 12 | 23% |
Testing and diagnosis research | 10 | 19% |
Laboratory research | 5 | 10% |
Disease patterns and progression | 4 | 8% |
Other research | 1 | 2% |
Mylonakis A (2026). [PMID: 42028479](https://pubmed.ncbi.nlm.nih.gov/42028479/). *Cureus*. [Case Report / Case Series]
Chiang S (2026). [PMID: 41086256](https://pubmed.ncbi.nlm.nih.gov/41086256/). *Annu Rev Pathol*. [Review / Meta-Analysis]
Wang L (2026). [PMID: 41285250](https://pubmed.ncbi.nlm.nih.gov/41285250/). *Mod Pathol*. [Diagnostic / Biomarker]
Watson GA (2026). [PMID: 42068680](https://pubmed.ncbi.nlm.nih.gov/42068680/). *Int J Gynecol Cancer*. [Review / Meta-Analysis]
Hartwich TMP (2026). [PMID: 41591910](https://pubmed.ncbi.nlm.nih.gov/41591910/). *Proc Natl Acad Sci U S A*. [Basic Science / Preclinical]
Brunetti M (2025). [PMID: 40403211](https://pubmed.ncbi.nlm.nih.gov/40403211/). *JCO Precis Oncol*. [Basic Science / Preclinical]
Wang C (2025). [PMID: 40123897](https://pubmed.ncbi.nlm.nih.gov/40123897/). *Front Oncol*. [Epidemiology / Natural History]
Wallwiener M (2025). [PMID: 40195954](https://pubmed.ncbi.nlm.nih.gov/40195954/). *Geburtshilfe Frauenheilkd*. [Epidemiology / Natural History]
Dundr P (2025). [PMID: 39627614](https://pubmed.ncbi.nlm.nih.gov/39627614/). *Virchows Arch*. [Basic Science / Preclinical]
Ricotta G (2025). [PMID: 40507372](https://pubmed.ncbi.nlm.nih.gov/40507372/). *Cancers (Basel)*. [Review / Meta-Analysis]